Michael Wang, Marc S Hoffmann, Tomasz Wróbel, Marek Trneny, David Belada, Fatih Demirken, Panayiotis Panayiotidis, Wojciech Jurczak, Pier Luigi Zinzani, Mary-Margaret Keating, Sung-Soo Yoon, Miklos Egyed, Constantine S. Tam, Nathalie A. Johnson, Edith Szafer Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Gottfried von Keudell. "First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations." Blood, 2026. doi:10.1182/blood.2025032833